Stephen Frank Mahoney
Chief Executive Officer en VIRIDIAN THERAPEUTICS, INC. .
Fortuna: 32 370 $ al 31/03/2024
Cargos activos de Stephen Frank Mahoney
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VIRIDIAN THERAPEUTICS, INC. | Director/Board Member | 30/10/2023 | - |
Chief Executive Officer | 30/10/2023 | - | |
President | 30/10/2023 | - | |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Director/Board Member | - | - |
Historial de carrera de Stephen Frank Mahoney
Antiguos cargos conocidos de Stephen Frank Mahoney.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DIANTHUS THERAPEUTICS, INC. | Chief Operating Officer | 01/11/2020 | 01/09/2023 |
Director of Finance/CFO | 01/11/2020 | 01/09/2023 | |
KINIKSA PHARMACEUTICALS, LTD. | Chief Operating Officer | 01/07/2015 | 15/11/2019 |
Founder | 01/07/2015 | 15/11/2019 | |
President | 01/06/2017 | 15/11/2019 | |
SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 05/11/2013 | 01/01/2015 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
MAGENTA THERAPEUTICS | Comptroller/Controller/Auditor | 02/11/2020 | 07/02/2023 |
Chief Operating Officer | 02/11/2020 | - | |
Director of Finance/CFO | 02/11/2020 | - | |
President | 07/02/2023 | - | |
Treasurer | 02/11/2020 | 07/02/2023 | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Formación de Stephen Frank Mahoney.
The Colorado College | Undergraduate Degree |
Boston College Law School | Graduate Degree |
Wallace E Carroll School of Management | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 12 |
Operativa
Corporate Officer/Principal | 3 |
Chief Operating Officer | 3 |
President | 3 |
Sectorial
Health Technology | 8 |
Consumer Services | 4 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
DIANTHUS THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Commercial Services |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |